Form 4: AbbVie CFO Scott Reents Executes Stock Option and Sells Shares
SEC Form 4 Filing
AbbVie's CFO, Scott Reents, exercised stock options and sold shares of common stock on February 23, 2024, according to a Form 4 filing with the SEC.
Summary
- Scott T. Reents, AbbVie's EVP and Chief Financial Officer, engaged in transactions involving AbbVie's common stock.
- On February 23, 2024, Reents exercised options to acquire 14,140 shares at a price of $61.36 per share.
- Simultaneously, Reents sold 14,140 shares at a weighted average price of $177.44, with individual sales ranging from $177.41 to $177.55.
- On February 28, 2024, Reents disposed of 11,634 shares at a price of $178.99.
- Following these transactions, Reents directly owns 15,431 shares of AbbVie common stock.
- Reents also holds options for 17,380 shares.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of stock transactions by an executive. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. The sale of shares by a CFO is not necessarily indicative of the company's performance, but it is a data point investors may consider.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership, but the overall impact is likely minimal.
Key Dates
| Date | Description |
|---|---|
| 02/16/2018 | Date the employee stock option was granted |
| 02/23/2024 | Date of stock option exercise and sale of shares. |
| 02/28/2024 | Date of disposal of shares. |
| 02/15/2027 | Expiration date of the employee stock option. |
| 03/01/2024 | Date of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.